Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer

BACKGROUND: Receptor tyrosine kinases promote tumor progression in many cancers, although oncologic activation differs between diffuse-type gastric cancer (DGC) and intestinal-type gastric cancer (IGC). Fibroblast growth factor receptor (FGFR) is one RTK, and we previously reported the clinical sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Inokuchi, Mikito, Murase, Hideaki, Otsuki, Sho, Kawano, Tatsuyuki, Kojima, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217622/
https://www.ncbi.nlm.nih.gov/pubmed/28056982
http://dx.doi.org/10.1186/s12957-016-1081-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217622/
https://www.ncbi.nlm.nih.gov/pubmed/28056982
http://dx.doi.org/10.1186/s12957-016-1081-4

Ejemplares similares